Amoeba SA (FR:ALMIB) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Amoéba’s new biofungicide AXPERA, developed in collaboration with IFV+, has shown promising results in controlling downy mildew in vines, achieving a 57.7% reduction in symptoms when combined with a reduced dose of copper. This innovative solution offers a sustainable alternative to traditional treatments and highlights its potential in combating fungal diseases under challenging conditions. The success of AXPERA marks a significant advancement in vineyard protection, meeting the urgent needs of winegrowers.
For further insights into FR:ALMIB stock, check out TipRanks’ Stock Analysis page.